UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The pharmacokinetics of fondaparinux sodium in healthy volunteers

Clinical pharmacokinetics, 2002, Vol.41 Suppl 2 (Supplement 2), p.1-9

2002

Volltextzugriff (PDF)

Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin)

Thrombosis and haemostasis, 1998-06, Vol.79 (6), p.1162-1165

1998

Volltextzugriff (PDF)

Absence of interaction of fondaparinux sodium with digoxin in healthy volunteers

Clinical pharmacokinetics, 2002, Vol.41 Suppl 2 (Supplement 2), p.39-45

2002

Volltextzugriff (PDF)

Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/Org31540) with high affinity to antithrombin III in man

Thrombosis and haemostasis, 1995-12, Vol.74 (6), p.1468-1473

1995

Volltextzugriff (PDF)

Pharmacokinetics of clopidogrel

Seminars in thrombosis and hemostasis, 1999, Vol.25 Suppl 2, p.25-28

1999

Volltextzugriff (PDF)

Human pharmacokinetics of tiludronate

Bone (New York, N.Y.), 1995-11, Vol.17 (5 Suppl), p.479S-S483

1995

Volltextzugriff (PDF)

Pharmacodynamics and tolerance of two nadroparin formulations (10,250 and 20,500 anti Xa IU x ml(-1)) delivered for 10 days at therapeutic dose

Thrombosis and haemostasis, 1998-02, Vol.79 (2), p.338-341

1998

Volltextzugriff (PDF)

Fondaparinux sodium mechanism of action: identification of specific binding to purified and human plasma-derived proteins

Clinical pharmacokinetics, 2002, Vol.41 Suppl 2 (Supplement 2), p.11-18

2002

Volltextzugriff (PDF)

The Synthetic Pentasaccharide Fondaparinux: First in the Class of Antithrombotic Agents that Selectively Inhibit Coagulation Factor Xa

Seminars in thrombosis and hemostasis, 2002-08, Vol.28 (4), p.393-402

2002

Volltextzugriff (PDF)

A Double Weibull Input Function Describes the Complex Absorption of Sustained-Release Oral Sodium Valproate

Journal of pharmaceutical sciences, 1994-10, Vol.83 (10), p.1461-1464

1994

Volltextzugriff (PDF)

Multiple dose pharmacokinetics of tiludronate in healthy volunteers

European journal of clinical pharmacology, 1996, Vol.51 (2), p.175-181

1996

Volltextzugriff (PDF)

Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis

Seminars in thrombosis and hemostasis, 1999, Vol.25 Suppl 2, p.41

1999

Volltextzugriff (PDF)

Cefpiramide kinetics and plasma protein binding in cholestasis

British journal of clinical pharmacology, 1994-03, Vol.37 (3), p.295-297

1994

Volltextzugriff (PDF)

Clopidogrel bioavailability: absence of influence of food or antacids

Seminars in thrombosis and hemostasis, 1999, Vol.25 Suppl 2, p.47-50

1999

Volltextzugriff (PDF)

Clopidogrel, a novel antiplatelet and antithrombotic agent

Cardiovascular drug reviews, 1993-06, Vol.11 (2), p.180-198

1993

Volltextzugriff (PDF)

Cirrhosis Does Not Affect the Pharmacokinetics and Pharmacodynamics of Clopidogrel

Journal of clinical pharmacology, 2000-04, Vol.40 (4), p.396-401

2000

Volltextzugriff (PDF)

Pharmacokinetics and protein binding of cefpiramide in patients with alcoholic cirrhosis

Clinical pharmacology and therapeutics, 1991-03, Vol.49 (3), p.263-269

1991

Volltextzugriff (PDF)

Influence of food and body weight on the pharmacokinetics of penticainide

Fundamental & clinical pharmacology, 1994-01, Vol.8 (5), p.453-457

1994

Volltextzugriff (PDF)

Clopidogrel does not affect the pharmacokinetics of theophylline

Seminars in thrombosis and hemostasis, 1999, Vol.25 Suppl 2, p.65

1999

Volltextzugriff (PDF)

Determination of circulating ethyl loflazepate metabolites in the baboon by radio-high-performance liquid chromatography with injection of crude plasma samples: Comparison with solvent extraction and thin-layer chromatography

Journal of chromatography, 1985-01, Vol.342 (1), p.159-165

1985

Volltextzugriff (PDF)

Clopidogrel does not affect the pharmacokinetics of theophylline: Clopidrogel, a New ADP-Receptor Antagonist: Clinical Development

Seminars in thrombosis and hemostasis, 1999, Vol.25 (2), p.65-68

1999

Volltextzugriff (PDF)

Electrophysiologic effects and pharmacokinetics of intravenous penticainide (CM 7857)

European heart journal, 1987-06, Vol.8 (6), p.618-623

1987

Volltextzugriff (PDF)

Clopidogrel activities in patients with renal function impairment

Clinical drug investigation, 1998, Vol.16 (4), p.319-328

1998

Volltextzugriff (PDF)

Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent

Cardiovascular drug reviews, 1993-06, Vol.11 (2), p.180-198

1993

Volltextzugriff (PDF)

SR 90107A/Org 31540, a Novel Anti‐Factor Xa Antithrombotic Agent

Cardiovascular drug reviews, 1997-03, Vol.15 (1), p.1-26

1997

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(49)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Humans
(31)
Life Sciences & Biomedicine
(29)
Biological And Medical Sciences
(27)
Medical Sciences
(27)
Pharmacology. Drug Treatments
(27)
Adult
(23)
Male
(22)
Pharmacology & Pharmacy
(16)
Cardiovascular System & Cardiology
(14)
Female
(14)
Blood. Blood Coagulation. Reticuloendothelial System
(12)
Adolescent
(10)
Hematology
(10)
Peripheral Vascular Disease
(10)
Aged
(9)
Ticlopidine - Analogs & Derivatives
(9)
Administration, Oral
(8)
Clopidogrel
(8)
Middle Aged
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The pharmacokinetics of fondaparinux sodium in healthy volunteers

Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin)

Absence of interaction of fondaparinux sodium with digoxin in healthy volunteers

Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/Org31540) with high affinity to antithrombin III in man

Pharmacokinetics of clopidogrel

Human pharmacokinetics of tiludronate

Pharmacodynamics and tolerance of two nadroparin formulations (10,250 and 20,500 anti Xa IU x ml(-1)) delivered for 10 days at therapeutic dose

Fondaparinux sodium mechanism of action: identification of specific binding to purified and human plasma-derived proteins

The Synthetic Pentasaccharide Fondaparinux: First in the Class of Antithrombotic Agents that Selectively Inhibit Coagulation Factor Xa

A Double Weibull Input Function Describes the Complex Absorption of Sustained-Release Oral Sodium Valproate

Multiple dose pharmacokinetics of tiludronate in healthy volunteers

Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis

Cefpiramide kinetics and plasma protein binding in cholestasis

Clopidogrel bioavailability: absence of influence of food or antacids

Clopidogrel, a novel antiplatelet and antithrombotic agent

Cirrhosis Does Not Affect the Pharmacokinetics and Pharmacodynamics of Clopidogrel

Pharmacokinetics and protein binding of cefpiramide in patients with alcoholic cirrhosis

Influence of food and body weight on the pharmacokinetics of penticainide

Clopidogrel does not affect the pharmacokinetics of theophylline

Determination of circulating ethyl loflazepate metabolites in the baboon by radio-high-performance liquid chromatography with injection of crude plasma samples: Comparison with solvent extraction and thin-layer chromatography

Clopidogrel does not affect the pharmacokinetics of theophylline: Clopidrogel, a New ADP-Receptor Antagonist: Clinical Development

Electrophysiologic effects and pharmacokinetics of intravenous penticainide (CM 7857)

Clopidogrel activities in patients with renal function impairment

Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent

SR 90107A/Org 31540, a Novel Anti‐Factor Xa Antithrombotic Agent

Suchergebnisse filtern